Global Next Generation Sequencing (NGS) Product Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Next Generation Sequencing (NGS) Product Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ1028493 | No. of Pages: 149 | Category: Medical Devices
Publisher: GRD Survey | Date of Publish: Nov-2021
Executive Summary

According to GRD Survey data, the global Next Generation Sequencing (NGS) Product market was valued at  million US$ in 2020 and is expected to reach  million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.

This report studies the Next Generation Sequencing (NGS) Product market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Next Generation Sequencing (NGS) Product in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Consumables and Reagents

    Instruments

    Others

Market Snapshot, By Application
    Life Science

    Traslational Medicine & Pharma

    Others

Main Market Players Analyzed in this report, including:
    Thermo Fisher Scientific

    Swift Biosciences

    Roche

    Rightongene Biotechnology

    QIAGEN

    Promega

    PerkinElmer

    Omixon

    Novogene

    Norgen Biotek

    NimaGen

    New England Biolabs

    Natera

    Mgi Tech

    LifeCodexx

    LabCorp

    Kindstar Global

    Illumina

    Find Biotechnology

    Eurofins Scientific

    Daan Gene

    CoWin Biotech

    Capitalbio

    BioCat GmbH

    BGI

    Berrygenomics

    Annaroad Gene Technology

    Amoy Diagnostics

    Agilent Technologies


The study objectives of this report are:
    To study and analyze the global Next Generation Sequencing (NGS) Product market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Next Generation Sequencing (NGS) Product market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Next Generation Sequencing (NGS) Product manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Next Generation Sequencing (NGS) Product market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Next Generation Sequencing (NGS) Product submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Next Generation Sequencing (NGS) Product are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Next Generation Sequencing (NGS) Product Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Next Generation Sequencing (NGS) Product Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Next Generation Sequencing (NGS) Product

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Next Generation Sequencing (NGS) Product Sales Channel and Distributors Analysis
        3.3.1 Next Generation Sequencing (NGS) Product Sales Channel
        3.3.2 Next Generation Sequencing (NGS) Product Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Life Science

        3.4.2 Major Buyers in Traslational Medicine & Pharma

    3.5 Next Generation Sequencing (NGS) Product Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Next Generation Sequencing (NGS) Product Type Introduction
        4.1.1 Consumables and Reagents

        4.1.2 Instruments

        4.1.3 Others
    4.2 Global Next Generation Sequencing (NGS) Product Sales by Type 2016-2021
    4.3 Global Next Generation Sequencing (NGS) Product Revenue by Type 2016-2021
    4.4 Global Next Generation Sequencing (NGS) Product Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Next Generation Sequencing (NGS) Product Type Introduction
        5.1.1 Life Science

        5.1.2 Traslational Medicine & Pharma

        5.1.3 Others
    5.2 Global Next Generation Sequencing (NGS) Product Sales by Application 2016-2021
    5.3 Global Next Generation Sequencing (NGS) Product Revenue by Application 2016-2021
    5.4 Global Next Generation Sequencing (NGS) Product Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Next Generation Sequencing (NGS) Product Market by Region
        6.1.1 Global Next Generation Sequencing (NGS) Product Sales by Regions
        6.1.2 Global Next Generation Sequencing (NGS) Product Revenue by Regions
    6.2 North America Next Generation Sequencing (NGS) Product Market 2016-2021
    6.3 Europe Next Generation Sequencing (NGS) Product Market 2016-2021
    6.4 Asia Pacific Next Generation Sequencing (NGS) Product Market 2016-2021
    6.5 South America Next Generation Sequencing (NGS) Product Market 2016-2021
    6.6 Middle East and Africa Next Generation Sequencing (NGS) Product Market 2016-2021

7 North America
    7.1 North America Next Generation Sequencing (NGS) Product Market by Country 2016-2021
        7.1.1 North America Next Generation Sequencing (NGS) Product Sales by Country
        7.1.2 North America Next Generation Sequencing (NGS) Product Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Next Generation Sequencing (NGS) Product Market by Country 2016-2021
        8.1.1 Europe Next Generation Sequencing (NGS) Product Sales by Country
        8.1.2 Europe Next Generation Sequencing (NGS) Product Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Next Generation Sequencing (NGS) Product Market by Country 2016-2021
        9.1.1 Asia Pacific Next Generation Sequencing (NGS) Product Sales by Country
        9.1.2 Asia Pacific Next Generation Sequencing (NGS) Product Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Next Generation Sequencing (NGS) Product Market by Country 2016-2021
        10.1.1 South America Next Generation Sequencing (NGS) Product Sales by Country
        10.1.2 South America Next Generation Sequencing (NGS) Product Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Next Generation Sequencing (NGS) Product Market by Country 2016-2021
        11.1.1 Middle East and Africa Next Generation Sequencing (NGS) Product Sales by Country
        11.1.2 Middle East and Africa Next Generation Sequencing (NGS) Product Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Thermo Fisher Scientific

        12.1.1 Thermo Fisher Scientific
 Company Information
        12.1.2 Thermo Fisher Scientific
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.1.3 Thermo Fisher Scientific
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Thermo Fisher Scientific
 Key Development
    12.2 Swift Biosciences

        12.2.1 Swift Biosciences
 Company Information
        12.2.2 Swift Biosciences
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.2.3 Swift Biosciences
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Swift Biosciences
 Key Development
    12.3 Roche

        12.3.1 Roche
 Company Information
        12.3.2 Roche
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.3.3 Roche
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Roche
 Key Development
    12.4 Rightongene Biotechnology

        12.4.1 Rightongene Biotechnology
 Company Information
        12.4.2 Rightongene Biotechnology
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.4.3 Rightongene Biotechnology
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Rightongene Biotechnology
 Key Development
    12.5 QIAGEN

        12.5.1 QIAGEN
 Company Information
        12.5.2 QIAGEN
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.5.3 QIAGEN
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 QIAGEN
 Key Development
    12.6 Promega

        12.6.1 Promega
 Company Information
        12.6.2 Promega
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.6.3 Promega
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Promega
 Key Development
    12.7 PerkinElmer

        12.7.1 PerkinElmer
 Company Information
        12.7.2 PerkinElmer
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.7.3 PerkinElmer
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Promega
 Key Development
    12.9 Novogene

        12.9.1 Novogene
 Company Information
        12.9.2 Novogene
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.9.3 Novogene
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Novogene
 Key Development
    12.8 Omixon

        12.8.1 Omixon
 Company Information
        12.8.2 Omixon
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.8.3 Omixon
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Omixon
 Key Development
    12.11 NimaGen

        12.11.1 NimaGen
 Company Information
        12.11.2 NimaGen
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.11.3 NimaGen
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.11.4 NimaGen
 Key Development
    12.12 New England Biolabs

        12.12.1 New England Biolabs
 Company Information
        12.12.2 New England Biolabs
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.12.3 New England Biolabs
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.12.4 New England Biolabs
 Key Development
    12.13 Natera

        12.13.1 Natera
 Company Information
        12.13.2 Natera
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.13.3 Natera
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.13.4 Natera
 Key Development
    12.14 Mgi Tech

        12.14.1 Mgi Tech
 Company Information
        12.14.2 Mgi Tech
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.14.3 Mgi Tech
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.14.4 Mgi Tech
 Key Development
    12.15 LifeCodexx

        12.15.1 LifeCodexx
 Company Information
        12.15.2 LifeCodexx
 Next Generation Sequencing (NGS) Product Product Portfolio, Specification and Application
        12.15.3 LifeCodexx
 Next Generation Sequencing (NGS) Product Sales, Price, Revenue and Gross Margin (2019-2021)
        12.15.4 LifeCodexx
 Key Development
    12.17 Kindstar Global

    12.18 Illumina

    12.19 Find Biotechnology

    12.20 Eurofins Scientific

    12.21 Daan Gene

    12.22 CoWin Biotech

    12.23 Capitalbio

    12.24 BioCat GmbH

    12.25 BGI

    12.26 Berrygenomics

    12.27 Annaroad Gene Technology

    12.28 Amoy Diagnostics

    12.29 Agilent Technologies


13 Global Next Generation Sequencing (NGS) Product Market Forecast by Region by Type and by Application
    13.1 Global Next Generation Sequencing (NGS) Product Sales, Revenue Forecast 2022-2027
    13.2 Global Next Generation Sequencing (NGS) Product Forecast by Regions
        13.2.1 Global Next Generation Sequencing (NGS) Product Sales Forecast by Region 2022-2027
        13.2.2 Global Next Generation Sequencing (NGS) Product Revenue Forecast by Region 2022-2027
    13.3 Global Next Generation Sequencing (NGS) Product Forecast by Type
        13.3.1 Global Next Generation Sequencing (NGS) Product Sales Forecast by Type 2022-2027
        13.3.2 Global Next Generation Sequencing (NGS) Product Revenue Forecast by Type 2022-2027
        13.3.3 Global Next Generation Sequencing (NGS) Product Price Forecast by Type 2022-2027
    13.4 Global Next Generation Sequencing (NGS) Product Forecast by Application
        13.4.1 Global Next Generation Sequencing (NGS) Product Sales Forecast by Application 2022-2027
        13.4.2 Global Next Generation Sequencing (NGS) Product Revenue Forecast by Application 2022-2027
        13.4.3 Global Next Generation Sequencing (NGS) Product Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com